TAK-653

TAK-653 (Osavampator) Research Standard

TAK-653 (Osavampator / NBI-1065845) is a synthetic pyrazinothiadiazine dioxide that functions as a positive allosteric modulator (PAM) of the AMPA-type glutamate receptor. By design, TAK-653 serves as a “glutamate-dependent” potentiator; it stabilizes the active conformation of the AMPA receptor specifically in the presence of endogenous glutamate, with minimal intrinsic agonist activity. This specific gating mechanism provides a distinct safety margin compared to earlier high-efficacy AMPA PAMs, which were historically associated with convulsive liability. In laboratory research, TAK-653 is a vital tool for studying the intricacies of AMPA receptor electrophysiology and the modulation of glutamatergic neurotransmission.

Technical Specifications

Mechanism of Action & Research Context

TAK-653 differentiates itself from first-generation AMPA potentiators through its unique interaction with the glutamate-binding pathway.

• Glutamate-Dependent Gating: The compound potentiates receptor currents only when endogenous glutamate is already bound to the receptor. This minimizes the risk of receptor over-activation (excitotoxicity) that plagued earlier, less-selective PAMs.

• Structural Interaction: Molecular modeling localizes the activity of TAK-653 to the Ser743 residue within the GluA1 subunit of the AMPA receptor.

• Minimal Intrinsic Agonism: Because it acts as a strictly agonist-dependent potentiator, it offers a refined chemical probe for investigating the physiological tuning of excitatory synapses without confounding seizure-related variables.

Research Applications

TAK-653 is an essential reagent for investigating the dynamics of the central nervous system’s excitatory pathways.

Primary fields of in vitro laboratory investigation include:

• AMPA Receptor Electrophysiology: Studying allosteric modulation and the kinetics of receptor current potentiation.

• Ca2+ Influx Assays: Utilizing hGluA1i-expressing cell lines to measure receptor sensitivity and response thresholds.

• Glutamate-Dependence & Desensitization: Investigating how the compound regulates desensitization kinetics under conditions of varying glutamate concentration.

• Comparative Reference: Providing a benchmark against high-efficacy AMPA PAMs to differentiate between therapeutic potential and convulsive liability in metabolic and neurobiological research models.

Storage & Handling Guidelines

To maintain the chemical stability and experimental reliability of the compound:

• Storage: Store at 2–8 °C. Ensure the container is tightly sealed to prevent environmental contamination.

• Light Sensitivity: Protect strictly from direct light, which may lead to degradation.

• Solvent Preparation: The compound is highly soluble in DMSO (~75 mg/mL) but is insoluble in water and ethanol. Prepare stock solutions in anhydrous DMSO under a dry nitrogen or argon atmosphere if long-term storage of the solution is required.

• Aseptic Technique: Use sterile, non-reactive laboratory tools to prevent cross-contamination during handling.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.